Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
出版年份 2018 全文链接
标题
Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
作者
关键词
Post-transplant lymphoproliferative disorder, PTLD, Rituximab, Adoptive T cell therapy
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 19, Issue 7, Pages -
出版商
Springer Nature
发表日期
2018-05-24
DOI
10.1007/s11864-018-0549-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- DA-EPOCH-R for post-transplant lymphoproliferative disorders
- (2017) Christin B. DeStefano et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
- (2017) Ralf U. Trappe et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review
- (2016) M. A. AlDabbagh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features
- (2016) J. Finalet Ferreiro et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy
- (2016) Mira Choi et al. TRANSPLANTATION
- The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
- (2015) M. R. Luskin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- How I treat posttransplant lymphoproliferative disorders
- (2015) D. Dierickx et al. BLOOD
- Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study
- (2015) M Wu et al. BONE MARROW TRANSPLANTATION
- Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
- (2015) Maria Raffaella Petrara et al. CANCER LETTERS
- Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation
- (2014) S. Choquet et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
- (2013) J. Morscio et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era
- (2013) A. M. Evens et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation
- (2013) U. D. Allen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
- (2013) J Sanz et al. BONE MARROW TRANSPLANTATION
- Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- (2013) Jan Styczynski et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
- (2013) M. Uhlin et al. HAEMATOLOGICA
- Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases
- (2013) An Herreman et al. LEUKEMIA & LYMPHOMA
- Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors
- (2013) Daan Dierickx et al. LEUKEMIA & LYMPHOMA
- Posttransplant Lymphoproliferative Disorder of the Central Nervous System
- (2013) Christian Kempf et al. PATHOBIOLOGY
- EBV and posttransplantation lymphoproliferative disease: what to do?
- (2013) H. Zimmermann et al. Hematology-American Society of Hematology Education Program
- Early Posttransplant Lymphoproliferative Disease
- (2012) Beverly P. Nelson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- How I treat HHV8/KSHV-related diseases in posttransplant patients
- (2012) G. Riva et al. BLOOD
- Burkitt post-transplantation lymphoma in adult solid organ transplant recipients
- (2012) Heiner Zimmermann et al. CANCER
- Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations
- (2012) Deepa Jagadeesh et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder
- (2012) Krzysztof Czyzewski et al. LEUKEMIA & LYMPHOMA
- T-cell therapy in the treatment of post-transplant lymphoproliferative disease
- (2012) Catherine M. Bollard et al. Nature Reviews Clinical Oncology
- Plasmablastic Posttransplant Lymphoma
- (2012) Heiner Zimmermann et al. TRANSPLANTATION
- EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue in the Posttransplant Setting
- (2011) Sarah E. Gibson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★
- (2011) R. Reshef et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder
- (2011) Jennifer Picarsic et al. CANCER
- Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases
- (2011) R. Trappe et al. HAEMATOLOGICA
- Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
- (2011) Ralf Trappe et al. LANCET ONCOLOGY
- Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant
- (2011) Denise K. Bonney et al. PEDIATRIC BLOOD & CANCER
- Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines
- (2010) Anne Parker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Primary central nervous system post-transplantation lymphoproliferative disorder
- (2010) Robert Cavaliere et al. CANCER
- Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder
- (2010) M. L. Gulley et al. CLINICAL MICROBIOLOGY REVIEWS
- The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
- (2010) A. Merlo et al. HAEMATOLOGICA
- Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era
- (2010) Andrew M. Evens et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder
- (2010) A. Patrick et al. JOURNAL OF NEURO-ONCOLOGY
- Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders
- (2010) Francesca Montanari et al. LEUKEMIA & LYMPHOMA
- Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
- (2010) K. Mucha et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer
- (2009) Kazuki Taoka et al. AMERICAN JOURNAL OF HEMATOLOGY
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Pathologic and Clinical Features of Hodgkin Lymphoma—Like Posttransplant Lymphoproliferative Disease
- (2009) Smita Krishnamurthy et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder
- (2008) C. Portell et al. BLOOD
- Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology
- (2008) Efsevia Vakiani et al. HEMATOLOGICAL ONCOLOGY
- Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system
- (2007) Gretha van de Glind et al. PEDIATRIC BLOOD & CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started